Aprea Therapeutics, Inc. Common stock (APRE)
Aprea Therapeutics, Inc. Common stock (APRE) has reported earnings 20 times since Aug 12, 2021. The stock moves an average of ±6.23% the day after reporting, closing higher 55.0% of the time. Its largest post-earnings gain was +13.64% (Mar 15, 2022) and its largest decline was -28.99% (May 16, 2022). The next earnings report is predicted for 2026-08-12 (estimated).
Earnings reactions
How APRE moved on each past earnings report.
Earnings Impact
Total Earnings
20
Avg Abs. Movement
±6.23%
Positive %
55.0%
Negative %
45.0%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 13, 2026 | ☀ PRE | -9.15% | open_in_new |
| Mar 16, 2026 | ☀ PRE | +2.51% | open_in_new |
| Nov 12, 2025 | ☀ PRE | +0% | open_in_new |
| Aug 12, 2025 | ☀ PRE | +0% | open_in_new |
Earnings Count
20
Total earnings in dataset
Avg Abs. Movement
±6.23%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260723 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 4 | 20260617 | open_in_new SEC.gov |
| 8-K | 20260617 | open_in_new SEC.gov |
Frequently asked about APRE earnings
When does Aprea Therapeutics, Inc. Common stock report earnings next? expand_more
Aprea Therapeutics, Inc. Common stock (APRE)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does APRE stock move after earnings? expand_more
Over 20 reports, APRE has moved an average of ±6.23% the session after earnings, closing higher 55.0% of the time.
What was APRE's biggest post-earnings move? expand_more
APRE's largest post-earnings gain on record was +13.64% on Mar 15, 2022, and its largest decline was -28.99% on May 16, 2022.
Where can I find Aprea Therapeutics, Inc. Common stock's SEC filings? expand_more
All of Aprea Therapeutics, Inc. Common stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right